Profile
Jeffrey H. Burbank is identified in the 2026 SEC filing as a director of Artivion, Inc. He serves on the board of the publicly traded medical device company Artivion, Inc., with no additional publicly disclosed roles provided in the filing context. Based on the given SEC filing context, this is his documented capacity relative to Artivion as of the filing date (May 21, 2026).
| Role | Director |
|---|
| Notability | 40/100 |
|---|
Board memberships
Awards & honors
- Director, Artivion, Inc. (as per 2026 SEC filing)
Frequently Asked Questions
Who is Burbank Jeffrey H?
Jeffrey H. Burbank is identified in the 2026 SEC filing as a director of Artivion, Inc. He serves on the board of the publicly traded medical device company Artivion, Inc., with no additional publicly disclosed roles provided in the filing context. Based on the given SEC filing context, this is his documented capacity relative to Artivion as of the filing date (May 21, 2026).…
How many SEC Form 4 filings has Burbank Jeffrey H submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Burbank Jeffrey H's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.